Results of the phase 2 and phase 3 clinical trials presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) has found that the single injected dose of the neuraminidase inhibitor (NAI) peramivir to be safe and effective in treating influenza symptoms if administered within 48 hours of the onset of symptoms. "Based on clinical data, peramivir is the first neuraminidase inhibitor (NAI) that has shown to be safe and effective as ...Sunday 7 September 2014
Single Dose Flu Vaccine Found to be Safe and Effective If Administered Within 48 Hours of Onset of Symptoms
Results of the phase 2 and phase 3 clinical trials presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) has found that the single injected dose of the neuraminidase inhibitor (NAI) peramivir to be safe and effective in treating influenza symptoms if administered within 48 hours of the onset of symptoms. "Based on clinical data, peramivir is the first neuraminidase inhibitor (NAI) that has shown to be safe and effective as ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment